The historical rank and industry rank for Consun Pharmaceutical Group's PB Ratio or its related term are showing as below:
HKSE:01681'
s PB Ratio Range Over the Past 10 Years
Min: 0.78 Med: 1.9 Max: 10.93
Current: 1.32
During the past 12 years, Consun Pharmaceutical Group's highest PB Ratio was 10.93. The lowest was 0.78. And the median was 1.90.
HKSE:01681's PB Ratio is ranked better than 67.12% of 949
companies
in the Drug Manufacturers industry
Industry Median: 1.88
vs HKSE:01681: 1.32
During the past 12 months, Consun Pharmaceutical Group's average Book Value Per Share Growth Rate was 12.40% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 15.10% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 13.90% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 11.70% per year.
During the past 12 years, the highest 3-Year average Book Value Per Share Growth Rate of Consun Pharmaceutical Group was 64.60% per year. The lowest was 8.10% per year. And the median was 11.60% per year.
Back to Basics: PB Ratio
Consun Pharmaceutical Group PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Consun Pharmaceutical Group's PB Ratio
For the Drug Manufacturers - Specialty & Generic subindustry, Consun Pharmaceutical Group's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Consun Pharmaceutical Group's PB Ratio Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Consun Pharmaceutical Group's PB Ratio distribution charts can be found below:
* The bar in red indicates where Consun Pharmaceutical Group's PB Ratio falls into.
Consun Pharmaceutical Group PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Consun Pharmaceutical Group (HKSE:01681) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Consun Pharmaceutical Group PB Ratio Related Terms
Thank you for viewing the detailed overview of Consun Pharmaceutical Group's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Consun Pharmaceutical Group (HKSE:01681) Business Description
Consun Pharmaceutical Group Ltd is a biotechnology company with sales operations throughout China. Its principal activities are making and selling pharmaceutical products. The company has two reportable segments: the Consun pharmaceutical segment, which is the key revenue driver, and makes and sells modern Chinese medicines and medical contrast medium, and the Yulin pharmaceutical segment, which manufactures and sells traditional Chinese medicines. Consun derives revenue from kidney medicines, contrast mediums, orthopedics medicines, dermatologic medicines, hepatobiliary medicines, medicines for women and children, and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:01681 has been successfully added to your 